The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
bobbust......very quiet is an understatement ! There must be something to this period off radio silence, no proactive interviews etc, at the same time the data stream must be trickling in if not flowing. Eventually something has to give GLA
Some are !....some are not ! A somewhat throwaway comment if you don't mind me saying ! What I would say is our new Non Ex Chair Dr Jean-Michel Cosséry is very much in tune with the corporate world of finance and as I have said before there must be something he finds interesting in our little corner shop Bio !!!!
I'm sure FDA would have notified Futura by now that this was a non-starter, rather than pursue further information. Furthermore a little worrying that it could be approved by the European Authorities etc and not by the FDA that would be saying something about those Authorities that have approved the product. The path to success is not always a smooth!
"It's a pity the wider market were not told that these trial results are 'Very Encouraging"
Maybe the "wider market" invest on the basis of proven financial return not just encouraging results?
Fortunately there are those who do invest in encouraging results, if it weren't for those that did and do I nothing would get done!
To be fair ndr50 I did use the live chat earlier this morning but was waylaid in posting, so it may only operate AM at the weekends. I would have thought almost certainly an RNS Monday to explain the reason behind it all or then again maybe not !
Monsieur Cosséry, is out of the top drawer. The question I ask myself why a minnow like Scancell ? He would have carried out due diligence he will have seen the data thus far, so I think it's fair to say he likes what he's see's. He has positions on other company boards and I'm sure has been invited to sit on many others but he chooses Scancell. He was in semi- retirement I believe, he then decides to increase his work load with his time and experience ( I doubt its money orientated) on a relatively small bio? Perhaps he see's this opportunity as potentially his greatest achievement yet, I certainly think his appointment to the Scancell board is our's.
aimho
Designed is correct ......it says so on Scancell's website under the heading Covidity . I also notice this .......Development of the COVID-19 vaccine is being carried out in collaboration with scientists in the newly established Centre for Research on Global Virus Infections and the new Biodiscovery Institute at the University of Nottingham, and Nottingham Trent University. The goal of the initial work is to assess safety and immune responses in a Phase 1 clinical trial.
I apologise if the above is already known !